Your browser is no longer supported. Please, upgrade your browser.
PETQ PetIQ, Inc. daily Stock Chart
PetIQ, Inc.
Index- P/E- EPS (ttm)-0.46 Insider Own1.00% Shs Outstand24.70M Perf Week14.47%
Market Cap771.88M Forward P/E31.19 EPS next Y1.00 Insider Trans- Shs Float13.87M Perf Month19.96%
Income-6.20M PEG- EPS next Q0.38 Inst Own- Short Float36.89% Perf Quarter54.24%
Sales314.70M P/S2.45 EPS this Y103.10% Inst Trans14.72% Short Ratio13.06 Perf Half Y41.98%
Book/sh9.04 P/B3.46 EPS next Y24.63% ROA- Target Price29.00 Perf Year37.54%
Cash/sh0.19 P/C164.23 EPS next 5Y25.00% ROE- 52W Range17.03 - 29.55 Perf YTD43.09%
Dividend- P/FCF- EPS past 5Y- ROI15.30% 52W High5.75% Beta-
Dividend %- Quick Ratio1.10 Sales past 5Y- Gross Margin17.40% 52W Low83.49% ATR1.69
Employees225 Current Ratio2.30 Sales Q/Q71.80% Oper. Margin- RSI (14)78.10 Volatility6.98% 4.83%
OptionableYes Debt/Eq0.99 EPS Q/Q-143.00% Profit Margin- Rel Volume18.12 Prev Close28.28
ShortableYes LT Debt/Eq0.98 EarningsAug 14 AMC Payout- Avg Volume391.69K Price31.25
Recom1.40 SMA2014.38% SMA5021.98% SMA20035.00% Volume7,097,182 Change10.50%
Aug-15-18 04:29PM  Why Chipotle Mexican Grill, Tilray, and PetIQ Jumped Today Motley Fool +10.50%
10:57AM  Why PetIQ, Inc. Is Soaring Today Motley Fool
08:51AM  PetIQ shares soar 10% after quarterly sales nearly double MarketWatch
Aug-14-18 04:28PM  PetIQ: 2Q Earnings Snapshot Associated Press
04:05PM  PetIQ, Inc. Reports Second Quarter 2018 Financial Results GlobeNewswire
02:30PM  PetIQ, Inc. Class A to Host Earnings Call ACCESSWIRE
Jul-24-18 08:00AM  PetIQ, Inc. to Report Second Quarter 2018 Results on Tuesday, August 14th GlobeNewswire
Jun-19-18 07:15AM  Free Stock Performance Review on Zoetis and Three Additional Generic Drugs Stocks ACCESSWIRE
Jun-06-18 08:00AM  PetIQ, Inc. to Participate in the Jefferies 2018 Consumer Conference GlobeNewswire
May-31-18 08:00AM  PetIQ, Inc. to Participate in the 38th Annual William Blair Growth Stock Conference GlobeNewswire
May-29-18 07:50AM  Blog Exposure - Karyopharm Inked Deal with Antengene for Development and Commercialization of Selinexor, Eltanexor, Verdinexor, and KPT-9274 in Asia ACCESSWIRE
May-17-18 04:25PM  PetIQ, Inc. (PETQ) Q1 2018 Earnings Conference Call Transcript Motley Fool -9.92%
May-15-18 04:51PM  PetIQ: 1Q Earnings Snapshot Associated Press
04:05PM  PetIQ, Inc. Reports First Quarter 2018 Financial Results GlobeNewswire
May-01-18 08:00AM  PetIQ, Inc. to Report First Quarter 2018 Results on Tuesday, May 15th GlobeNewswire
Apr-02-18 04:05PM  PetIQ, Inc. Files Pro Forma Financial Results for the Acquisition of VIP Petcare GlobeNewswire
Mar-27-18 08:00AM  PetIQ, Inc. to Release Pro Forma Financial Results for the Acquisition of VIP Petcare on Monday, April 2nd GlobeNewswire
Mar-19-18 04:05PM  PetIQ, Inc. Expands Its Board of Directors GlobeNewswire
Mar-14-18 08:53AM  Benzinga Pro's 5 Stocks To Watch Today Benzinga +9.60%
Mar-13-18 06:26PM  8 Stocks Moving In Tuesday's After-Hours Session Benzinga
04:55PM  PetIQ reports 4Q loss Associated Press
04:06PM  PetIQ, Inc. Announces the Expansion of its Veterinary Services Offering in the Mass Retail Channel GlobeNewswire
04:05PM  PetIQ, Inc. Reports Fourth Quarter and Full Year 2017 Financial Results GlobeNewswire
Feb-26-18 08:00AM  PetIQ, Inc. to Report Fourth Quarter and Fiscal 2017 Results on Tuesday, March 13th GlobeNewswire
Jan-17-18 05:06PM  PetIQ, Inc. Completes Strategic Acquisition of VIP Petcare GlobeNewswire
Oct-16-17 08:32AM  PetIQ, Inc. breached its 50 day moving average in a Bearish Manner : PETQ-US : October 16, 2017 Capital Cube
Sep-07-17 03:00AM  IBD Rating Upgrades: Michaels Flashes Improved Price Strength Investor's Business Daily
PetIQ, Inc. develops, manufactures, and distributes pet medications, and health and wellness products for dogs and cats in the United States, Canada, and Europe. It offers pet prescription medications, including products for arthritis, thyroid, and diabetes and pain treatments, as well as heartworm preventatives, antibiotics, and other specialty medications; over-the-counter medications and supplies, such as flea and tick control products in various forms comprising spot on treatments, chewables, and collars; and health and wellness products consisting of specialty treats and other pet products, which include dental treats and nutritional supplements. The company provides its products primarily under the VetIQ, PetAction Plus, Advecta, PetLock Plus, and TruProfen brands. It sells its products through distributors as well as through retail stores, including approximately 40,000 retail pharmacy locations. PetIQ, Inc. was founded in 2010 and is headquartered in Eagle, Idaho.